Only Covance combines one of the world’s largest sources of de-identified lab results and patient intelligence data with investigator data from the majority of global clinical trials that provide insights to increase efficiencies and effectiveness in clinical drug development.
Find patients that Meet Your Inclusion/Exclusion Criteria
Using LabCorp’s real world, de-identified clinical laboratory data on over 150 million patients, we can assess populations who meet your protocol’s eligibility criteria, accurately model the impact that the protocol inclusion/exclusion criteria will have on the patient pool size and geo-locate
Combining four unique data sets with our therapeutic and functional expertise, Covance can impact protocol design and feasibility, optimal site selection, and patient recruitment.
Covance Unique-to-the-Industry Data Sets Help Achieve Faster Recruitment and Better Study Outcomes
Fixing the Leaky Patient Recruitment Funnel
See how Covance combines data with powerful analytics and technology to improve study outcomes
*Savings based on an analysis of trials processed through Covance Central Labs with Protocol Finalization date after 1/1/2009 for the specific clinical indications. Past performance is not a guarantee of future results, and a variety of factors other than CRO performance can impact timing of clinical studies.